Chemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRC
Status:
Withdrawn
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess feasibility of chemoembolization with DC Bead loaded
with Irinotecan in combination with Cetuximab and 5FU/LV as a first line treatment for
wildtype KRAS unresectable liver metastases from colorectal cancer.